ASH Clinical News ACN_4.11_Full Issue_web | Page 62

The Break Room Tweet Like Everyone’s Watching Condensing information was my gateway, and I quickly found more uses for Twitter beyond filtering the latest and greatest from PubMed. It became a new outlet for interacting with col- leagues and patients, and even bringing attention to various issues that I felt were important. However, with that kind of visibility comes great responsibility. Social media’s predominance in our personal and professional lives is a double- edged sword: Everyone can see your activity, so you can reach a huge audience with your message and you can pull information from large swaths of the population. That also means that people can see any negative interactions you’re having, as well. We’ve had countless examples from enter- tainment, politics, and pop culture: Anything you put online is there for all eternity. I’ve certainly fallen into the trap of having unpro- ductive discussions through Twitter. So now, when I’m getting ready to send something out to my followers – and, really, anyone with an internet connection who might happen across my profile – I listen to the voice in the back of my head that tells me, “Patients and colleagues may see this.” I didn’t even realize how many of my pa- tients were on Twitter until Elaine Schattner, MD (@ESchattner), a health-care advocate and former physician who has a large Twitter presence, suggested I take a look at my follow- ers list. I was totally shocked to see how many non–health-care providers were on it. My audi- ence was much different than I thought and discovering that has made me a more effective communicator. My advice is to tweet like everyone’s watch- ing. Don’t post something you’ll regret. Still, I think we should be embracing patients on so- cial media, rather than shying away from them. I had the pleasure of participating in a Twitter chat with patients through #MPNSM, where we live-tweeted for over an hour, answered tons of questions from participants, and had thought- ful conversations with them – not to mention with the hundreds more who were probably following the conversations but not writing in. It reminded me of the patient symposia we hold at our institute; patients can come in and listen to lectures from experts in the field. But, through Twitter, we were able to do it live, or- ganize it quickly, and deliver it to anyone who searched the hashtag. Patients and Privacy There is a distinct advantage to opening lines of communication through Twitter: When patients enter the doctor’s office, there is an unmistakable hierarchy; in that formal setting, patients may feel uncomfortable asking certain questions, or may forget to ask the questions they wanted to ask. Interacting with patients on Twitter removes some of that formality. People may feel more comfortable having virtual conversations outside of the confines of the doctor’s office or clinic. As many advantages as it provides, there are undeniable limitations of using Twitter as a platform for patient interaction. I get tweets from people identifying as MPN patients who ask me for my thoughts about a treatment or 60 ASH Clinical News for a second opinion. Of course, I can’t perform a full history and physical over Twitter, so it’s impossible to make a fully informed evaluation. However, I can provide general information and steer them to various resources. We also are governed by patient confidential- ity and HIPAA laws, so the transparency and in- formality inherent to social media is often at odds with the patient protections built into the U.S. health-care system. Interacting with a Twitter avatar, rather than an “in-real-life” patient, means I can’t perform “the eyeball test” that clinicians rely heavily on in day-to-day practice: When you walk into a room and start talking to patients, subtle, non- verbal communication cues can give you a sense of what they do, how active they are, and how their disease has affected their lives. These are factors we consider in our treatment discussions; they’re also things you can’t discern from virtual patient interactions. My strategy is to give patients as much infor- mation as I can, but I can only explain so much through 280 characters and limited background information. If I can’t answer a question in the context of Twitter, I’ll respond with, “That’s a great question and an important topic. I have a hard time answering that question, but you and your doctor can discuss it.” In some cases, I steer people toward one of my colleagues in their region who can give them more in-depth information or direct them to a nearby clinical trial center if they have questions about investigational treatments. Obviously, Twitter is never going to take the place of an actual face-to-face, physician-patient interaction, but it certainly augments what we do. If we keep it professional and recognize the limi- tations of this type of interaction, it only makes sense for hematologists to leverage this platform to reach our intended audience. Also, many of our patients are likely already on Twitter – shouldn’t we join them? ● Hematology Hashtags Memorize this list of hematology hashtags to get ready for #ASH18! #ASHsm #MPNsm #VTE #ASHaiku #pallonc #hemophilia #BMTsm #immunoonc #TcellRx #MMsm #sicklecell #leusm #transfusion #lymsm #hpm Nervous about signing up for a Twitter account? Dr. Gerds offers some advice for overcoming your fears. Log on and show up. “As the saying goes, ‘Ninety percent of success is showing up.’ Social media platforms are incredibly intuitive, so just by being there, you can pick up a lot of information about how to use it to your advantage.” Take inspiration from those you follow. “You don’t have to tweet a lot at the beginning, but start following people and look at the conversations they’re having. Notice what sticks out to you when you’re scrolling through the feed, or what type of content started a co